In addition to known GBM drivers, the top hits list contained genes previously not associated with GBM, such as DLK2, CEACAM7 and RPL37 (Fig. 5C and Supplementary Table S3)—novel candidate genes to be tested for their role in tumorigenesis. This evidence concerns the gene RPL37 and glioblastoma.